PT-141

Name: PT-141
Brand: ONE%
SKU: PEP-PT141-10
Price: 59 EUR
Availability: InStock

Melanocortin receptor agonist

PT-141 is a synthetic peptide studied as a melanocortin-receptor agonist, examined in the research literature for its activity on central nervous system arousal pathways.

Limited supply

€59 Vial · 10mg · per unit, excl. shipping

Every order includes ultra-fine injectable needles and alcohol swabs, the smallest gauge, highest-grade, ready to use.

UPS Standard · €193-5 days, all EU

UPS Express · €2924-48 hours across the EU

Tracked, cold-chain and discreetly packaged. Choose your speed at checkout.

CategoryDESIRE · Libido

FormatVial

In The BoxNeedles + alcohol swabs

Dose10mg

DeliveryUPS Standard 3-5 days · UPS Express 24-48h

Purity Target>99%

Also: request a COA or a wholesale quote.

Third-party testedCOA per batchCold-chain EU shippingDiscreet packaging

Add the instrument ONE% Pen Reusable machined aluminium. Buy once, it works with any compound.

€49

Complete the kit ONE% Cartridges · 5-pack Sterile replacement cartridges for the ONE% Pen.

€39

Research Overview

PT-141 is a synthetic peptide studied as a melanocortin-receptor agonist, examined in the research literature for its activity on central nervous system arousal pathways.

PT-141 is studied for agonist activity at MC3R/MC4R melanocortin receptors, implicated in central arousal-pathway research.

Because responses in this class of research are dose- and purity-sensitive, impurity shows up directly as noise in the data. ONE% supplies PT-141 lyophilised, batch-verified, so the signal being measured stays clean from study to study.

Mechanism In Brief

PT-141 is studied for agonist activity at MC3R/MC4R melanocortin receptors, implicated in central arousal-pathway research.

Areas Of Research Interest

Melanocortin receptor (MC3R/MC4R), pharmacology
Central arousal-pathway, research
Comparative studies, with other melanocortin agonists
Dose-response research models
Receptor-selectivity studies

Handling & Reconstitution

Every ONE% compound ships as a lyophilised powder for stability in transit. Reconstitute with bacteriostatic water to the concentration your protocol requires, store at 2–8°C protected from light, and use within your laboratory’s validated window. Each vial is batch-referenced to its Janoshik Certificate of Analysis, available on request.

Compound FamilyMelanocortin receptor agonist

FormLyophilised powder

PresentationSingle sealed vial

ReconstitutionBacteriostatic water

Storage2–8°C, protect from light

Important

For research and laboratory use only. PT-141 is supplied strictly as premium-grade research material with a batch Certificate of Analysis. It is not a drug, supplement, food, or cosmetic, and is not intended for human or veterinary use, diagnosis, treatment, or the prevention of any condition. All statements describe published research directions only.

Good To Know

Common Questions.

It ships as a lyophilised (freeze-dried) powder. In the lab it's reconstituted with bacteriostatic water to the concentration your protocol requires. Kept sealed, cold and dark, it stays stable until you need it.

Sealed at 2–8°C, protected from light. As a lyophilised powder it's stable in transit; once reconstituted, follow your laboratory's validated window.

No, every compound ships as a lyophilised vial and is reconstituted in the lab. The ONE% Pen is a separate reusable instrument for laboratories that want repeatable, graduated delivery instead of drawing by syringe each time. Buy it once; it is not tied to any one compound.

Every vial carries a batch code. Enter it on our batch verification page to pull up that batch’s Certificate of Analysis, or ask us for the certificate before you order, we would rather you check than take our word for it.

It is the target every batch of PT-141 is held to, measured by HPLC at Janoshik and reported on the COA as a percentage of the total peptide content. Identity is confirmed separately by mass spectrometry. A purity figure without a named method and a batch reference behind it is marketing, not data.